244 related articles for article (PubMed ID: 34778851)
1. Machine learning and network medicine approaches for drug repositioning for COVID-19.
Santos SS; Torres M; Galeano D; Sánchez MDM; Cernuzzi L; Paccanaro A
Patterns (N Y); 2022 Jan; 3(1):100396. PubMed ID: 34778851
[TBL] [Abstract][Full Text] [Related]
2. The Coronavirus Network Explorer: mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function.
Krämer A; Billaud JN; Tugendreich S; Shiffman D; Jones M; Green J
BMC Bioinformatics; 2021 May; 22(1):229. PubMed ID: 33941085
[TBL] [Abstract][Full Text] [Related]
3. Signaling repurposable drug combinations against COVID-19 by developing the heterogeneous deep herb-graph method.
Yang F; Zhang S; Pan W; Yao R; Zhang W; Zhang Y; Wang G; Zhang Q; Cheng Y; Dong J; Ruan C; Cui L; Wu H; Xue F
Brief Bioinform; 2022 Sep; 23(5):. PubMed ID: 35514205
[TBL] [Abstract][Full Text] [Related]
4. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
Su X; Hu L; You Z; Hu P; Wang L; Zhao B
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Potential Therapeutic Drugs for COVID-19 Through Logistic Matrix Factorization With Kernel Diffusion.
Tian X; Shen L; Gao P; Huang L; Liu G; Zhou L; Peng L
Front Microbiol; 2022; 13():740382. PubMed ID: 35295301
[TBL] [Abstract][Full Text] [Related]
6. SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
Fiscon G; Conte F; Farina L; Paci P
PLoS Comput Biol; 2021 Feb; 17(2):e1008686. PubMed ID: 33544720
[TBL] [Abstract][Full Text] [Related]
7. Drug repositioning for SARS-CoV-2 by Gaussian kernel similarity bilinear matrix factorization.
Wang Y; Xiang J; Liu C; Tang M; Hou R; Bao M; Tian G; He J; He B
Front Microbiol; 2022; 13():1062281. PubMed ID: 36545200
[TBL] [Abstract][Full Text] [Related]
8. Repurposing potential of FDA-approved and investigational drugs for COVID-19 targeting SARS-CoV-2 spike and main protease and validation by machine learning algorithm.
Verma AK; Aggarwal R
Chem Biol Drug Des; 2021 Apr; 97(4):836-853. PubMed ID: 33289334
[TBL] [Abstract][Full Text] [Related]
9. Attention Mechanism-Based Graph Neural Network Model for Effective Activity Prediction of SARS-CoV-2 Main Protease Inhibitors: Application to Drug Repurposing as Potential COVID-19 Therapy.
Wu Y; Li K; Li M; Pu X; Guo Y
J Chem Inf Model; 2023 Nov; 63(22):7011-7031. PubMed ID: 37960886
[TBL] [Abstract][Full Text] [Related]
10. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
[TBL] [Abstract][Full Text] [Related]
11. DrugRep-HeSiaGraph: when heterogenous siamese neural network meets knowledge graphs for drug repurposing.
Ghorbanali Z; Zare-Mirakabad F; Salehi N; Akbari M; Masoudi-Nejad A
BMC Bioinformatics; 2023 Oct; 24(1):374. PubMed ID: 37789314
[TBL] [Abstract][Full Text] [Related]
12. Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2.
Zhou Y; Hou Y; Shen J; Huang Y; Martin W; Cheng F
Cell Discov; 2020; 6():14. PubMed ID: 32194980
[TBL] [Abstract][Full Text] [Related]
13. Knowledge Graph-Based Approaches to Drug Repurposing for COVID-19.
Al-Saleem J; Granet R; Ramakrishnan S; Ciancetta NA; Saveson C; Gessner C; Zhou Q
J Chem Inf Model; 2021 Aug; 61(8):4058-4067. PubMed ID: 34297570
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2-host proteome interactions for antiviral drug discovery.
Liu X; Huuskonen S; Laitinen T; Redchuk T; Bogacheva M; Salokas K; Pöhner I; Öhman T; Tonduru AK; Hassinen A; Gawriyski L; Keskitalo S; Vartiainen MK; Pietiäinen V; Poso A; Varjosalo M
Mol Syst Biol; 2021 Nov; 17(11):e10396. PubMed ID: 34709727
[TBL] [Abstract][Full Text] [Related]
15. Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing.
Sadegh S; Matschinske J; Blumenthal DB; Galindez G; Kacprowski T; List M; Nasirigerdeh R; Oubounyt M; Pichlmair A; Rose TD; Salgado-Albarrán M; Späth J; Stukalov A; Wenke NK; Yuan K; Pauling JK; Baumbach J
Nat Commun; 2020 Jul; 11(1):3518. PubMed ID: 32665542
[TBL] [Abstract][Full Text] [Related]
16. Identification of oral therapeutics using an AI platform against the virus responsible for COVID-19, SARS-CoV-2.
Bess A; Berglind F; Mukhopadhyay S; Brylinski M; Alvin C; Fattah F; Wasan KM
Front Pharmacol; 2023; 14():1297924. PubMed ID: 38186640
[No Abstract] [Full Text] [Related]
17. Lung disease network reveals impact of comorbidity on SARS-CoV-2 infection and opportunities of drug repurposing.
Das AB
BMC Med Genomics; 2021 Sep; 14(1):226. PubMed ID: 34535131
[TBL] [Abstract][Full Text] [Related]
18. Machine Learning Applications in Drug Repurposing.
Yang F; Zhang Q; Ji X; Zhang Y; Li W; Peng S; Xue F
Interdiscip Sci; 2022 Mar; 14(1):15-21. PubMed ID: 35066811
[TBL] [Abstract][Full Text] [Related]
19. Drug Repurposing for COVID-19 using Graph Neural Network with Genetic, Mechanistic, and Epidemiological Validation.
Hsieh K; Wang Y; Chen L; Zhao Z; Savitz S; Jiang X; Tang J; Kim Y
Res Sq; 2020 Dec; ():. PubMed ID: 33330858
[TBL] [Abstract][Full Text] [Related]
20. Network machine learning maps phytochemically rich "Hyperfoods" to fight COVID-19.
Laponogov I; Gonzalez G; Shepherd M; Qureshi A; Veselkov D; Charkoftaki G; Vasiliou V; Youssef J; Mirnezami R; Bronstein M; Veselkov K
Hum Genomics; 2021 Jan; 15(1):1. PubMed ID: 33386081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
